Ajanta Pharma Limited has informed the Exchange regarding a press release dated August 30, 2023, titled "Ajanta receives final approval from US FDA forTopiramate Extended Release Capsules".
Ajanta Pharma Limited has informed the Exchange regarding a press release dated August 30, 2023, titled "Ajanta receives final approval from US FDA forTopiramate Extended Release Capsules".